Please assess the completion status of the following clinical trial:

Trial Title: A Randomized,Parallel-group Clinical Trial of Hepatitis B Vaccine With Different Dosages and Schedules in Healthy Adults

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Healthy subjects aged between 16 and 25 as established by medical history and clinical examination~* Written informed consent will be obtained from each subject before the serum screening of HBV markers~* Seronegative for HBsAg, anti-HBs antibody, anti-HBc antibody~* Have never been immunized with HBV vaccine before~Exclusion Criteria:~* Subject has a medical history of allergic to any ingredient of vaccine~* Family history of seizures or progressive neurological disease~* Autoimmune disease or immunodeficiency~* Women with pregnant~* Bleeding disorder diagnosed by a doctor~* Chronic diseases: hepatitis, tumor, tuberculosis,et.al~* Any prior administration of immunoglobulins or blood products in the last 3 mon before recruitment~* Subjects had a medical history of serious adverse reactions to vaccines

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 25 Years
- Healthy Volunteers: f

Study Arms:
- 20μg, 0-1-6 (Type: ACTIVE_COMPARATOR): 117 young adults were administered with 20μg of hepatitis B vaccine according to the 0-1-6 mon schedule.
- 60μg, 0-1 (Type: EXPERIMENTAL): 112 young adults were administered with 60μg of hepatitis B vaccine according to the 0-1 mon schedule.
- 60μg, 0-2 (Type: EXPERIMENTAL): 125 young adults were administered with 60μg of hepatitis B vaccine according to the 0-2 mon schedule.

Based on this trial design, predict the completion outcome and termination type (if applicable).